CYNTHIA KNIGHT: Open Payments
NPI 1134199029 · SEAFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 43 payments from 22 companies in 2025. Trend: 2023 $792 · 2024 $906 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $138 |
| ABBVIE INC. | 4 | $77 |
| UCB, Inc. | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Lilly USA, LLC | 3 | $64 |
| GENZYME CORPORATION | 2 | $56 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Abbott Laboratories | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 3 | $38 |
Products named: Rybelsus, JARDIANCE, MOUNJARO, Ozempic, DUPIXENT, Rystiggo, GARDASIL 9, QULIPTA.
Industry payments across DE — which companies pay providers there.
